{
  "guideline": {
    "id": "PA166265201",
    "name": "Annotation of DPWG Guideline for oxcarbazepine and HLA-B",
    "source": "DPWG",
    "version": 6,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166265201",
    "relatedChemicals": [
      {
        "id": "PA450732",
        "name": "oxcarbazepine",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA35056",
        "name": "major histocompatibility complex, class I, B",
        "symbol": "HLA-B"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166299118",
      "name": "Recommendation PA166299118",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450732",
          "name": "oxcarbazepine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061481,
        "html": "<ul>\n<li>Carefully weigh the risk of SJS against the benefits.</li>\n<li>Avoid oxcarbazepine if an alternative is available.\n<ul>\n<li>Carbamazepine carries a 10-fold higher risk of SJS/TEN in these patients and is therefore not an alternative.</li>\n<li>In these patients, phenytoin and lamotrigine carry a similar risk of SJS/TEN as oxcarbazepine, but more severe forms of SJS/TEN (SJS/TEN overlap and TEN) are also\nobserved with these medicines. Therefore, they are also not suitable as alternatives.</li>\n</ul>\n</li>\n<li>If it is not possible to avoid oxcarbazepine, advise the patient to report any rash immediately</li>\n</ul>\n"
      },
      "implications": [
        "Stevens-Johnson syndrome, the severe cutaneous side effect that can potentially result in permanent damage, occurs more often in patients with this genetic variation. The calculated risk of oxcarbazepine-induced SJS in patients with HLA-B*1502 is 0.73%."
      ],
      "lookupKey": {
        "HLA-B": "*15:02 positive"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": true
    }
  ],
  "citations": [],
  "version": "2023-12-19-10-38"
}